Solventum Corp（SOLV）のニュースとイベントSOLVSolventum Corp

Solventum Receives FDA 510(k) Clearance for Restrata and V.A.C. Therapy

Solventum announced that the FDA has granted 510(k) clearance for the combined use of Restrata Synthetic Electrospun Fiber Matrix and Solventum V.A.C.( Therapy. Following Solventum's acquisition of Acera Surgical in December 2025, this regulatory milestone brings two technologies together into one path to support active wound healing. Restrata Matrix and V.A.C. Therapy are engineered to support various stages of the healing journey: Restrata is a 100% synthetic, fully resorbable matrix engineered to support soft tissue healing. V.A.C. Therapy delivers negative pressure wound therapy to create an environment that promotes wound healing. When used with dressings like Solventum V.A.C. Peel and Place Dressing, V.A.C. Therapy helps maintain close contact between the matrix and the wound bed.

Stock Futures Mixed in After-Hours Trading

Stock futures were mixed in after-hours trading following Wednesday's mixed finish during the regular session. Investors continue to weigh new waves of corporate earnings against continued tensions in the Middle East.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -SiTimeup 33.9%SoundHoundup 21.8%Aevaup 18.9%Paycomup 15.1%ZoomInfoup 7%Motorola Solutionsup 5.2%Solventumup 3.4%DOWN AFTER EARNINGS -BillionToOnedown 27.6%HubSpotdown 19.7%UWM Holdingsdown 17.9%AppLovindown 16.5%Sunrundown 13.9%Western Digitaldown 10.9%Zillowdown 9.2%CF Industriesdown 6.1%Axon Enterprisesdown 5%ThredUpdown 1.8%